Clinical trials: CVD Risk Factors
Gender Incongruence, Cardiovascular Disease (CVD) Risk Factors
Cardiomodulatory Effects of Gender-Affirming Hormone Therapy
Gender-affirming hormone therapy is today a well-established treatment for individuals experiencing gender-incongruence. However, little is known about the long-term effects of gender-affirming hormone therapy on the…
- Trial name
- CARMEN (NCT07128771)
- Where
- Norway
- Volunteers
- 450 people, healthy volunteers welcome
- Sponsor
- University Hospital, Akershus
Cardiovascular Disease (CVD) Risk Factors
Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk (FIT)
The primary research question of this study is to determine whether measuring, reporting and feeding back information to primary care teams on the need for treatment intensification in patients at high risk for cardiovascular…
- Trial name
- FIT (NCT00517686)
- Testing
- Information feedback intervention
- Where
- United States
- Volunteers
- 16,584 people
- Sponsor
- Kaiser Permanente
To Assess the Impact of the HIT Intervention on Physiological Responses, To Assess the Role of a Secondary High School as a Setting for Promoting Healthy Eating and PA Behaviours
The Influence of a High Intensity Physical Activity Intervention on a Selection of Health Related Outcomes: An Ecological Approach
The purpose of this study is to determine whether a High Intensity exercise intervention can elicit cardiovascular disease protection in adolescents.
- Conditions
- To Assess the Impact of the HIT Intervention on Physiological Responses, To Assess the Role of a Secondary High School as a Setting for Promoting Healthy Eating and PA Behaviours, To Determine the Associations Between CVD Risk Factors at Baseline in 15 - 18 Year Old Youth
- Trial name
- NCT01027156
- Testing
- High Intensity Exercise
- Where
- United Kingdom
- Volunteers
- healthy volunteers welcome
- Sponsor
- University of the West of Scotland